QUOTE AND NEWS
GenEng News  Jun 21  Comment 
Much of the etiology of Parkinson’s disease (PD) was thought to be well established, with the noted exception of the hypothesis that has been kicked around for almost a century that PD is partly an autoimmune disorder. Unfortunately, previous...
GenEng News  Jun 19  Comment 
An international research team says it has discovered a new kind of immune cell that could predict which lung cancer patients will benefit most from immunotherapy treatment. The group's study ("Tissue-Resident Memory Features Are Linked to the...
Benzinga  May 22  Comment 
Following the publication of full data from a late-stage study of La Jolla Pharmaceutical Company (NASDAQ: LJPC)'s LPJC-501, a proprietary formulation of angiotensin II, SunTrust Robinson Humphrey said it expects approval in 2018. The Study And...
Benzinga  May 22  Comment 
Shares of La Jolla Pharmaceutical Company (NASDAQ: LJPC) were trading lower by more than 8 percent Monday morning after the company released Phase 3 results in the New England Journal of Medicine from a study called ATHOS-3, which evaluated the...
FierceBiotech  May 22  Comment 
La Jolla Pharmaceutical has posted a full look at data from a phase 3 trial of its vasodilatory shock candidate LJPC-501. Key findings are in line with the earlier, positive top-line data drop but the picture becomes muddier beyond the primary...
Motley Fool  May 18  Comment 
Shares jump after the company reports that the results from its ATHOS-3 study will be published in the New England Journal of Medicine.





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki